|
1
|
Brunacci C, Piobbico D, Bartoli D,
Castelli M, Pieroni S, Bellet MM, Viola-Magni M, Della Fazia MA and
Servillo G: Identification and characterization of a novel peptide
interacting with cAMP-responsive elements binding and
cAMP-responsive elements modulator in mouse liver. Liver Int.
30:388–395. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gilchrist M, Henderson WR Jr, Morotti A,
Johnson CD, Nachman A, Schmitz F, Smith KD and Aderem A: A key role
for ATF3 in regulating mast cell survival and mediator release.
Blood. 115:4734–4741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Du Z and Jiang B: The research progress of
ATF3 and tumor. J Gannan Univ Med. 30:163–166. 2010.
|
|
4
|
Tamura K, Hua B, Adachi S, Guney I,
Kawauchi J, Morioka M, Tamamori-Adachi M, Tanaka Y, Nakabeppu Y,
Sunamori M, et al: Stress response gene ATF3 is a target of c-myc
in serum-induced cell proliferation. EMBO J. 24:2590–2601. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Taketani K, Kawauchi J, Tanaka-Okamoto M,
Ishizaki H, Tanaka Y, Sakai T, Miyoshi J, Maehara Y and Kitajima S:
Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of
human colon cancer cells. Oncogene. 31:2210–2221. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yin X, Wolford CC, Chang YS, McConoughey
SJ, Ramsey SA, Aderem A and Hai T: ATF3, an adaptive-response gene,
enhances TGF-{beta} signaling and cancer-initiating cell features
in breast cancer cells. J Cell Sci. 123:3558–3565. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma S, Pang C, Song L, Guo F and Sun H:
Activating transcription factor 3 is overexpressed in human glioma
and its knockdown in glioblastoma cells causes growth inhibition
both in vitro and in vivo. Int J Mol Med. 35:1561–1573. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tanaka Y, Nakamura A, Morioka MS, Inoue S,
Tamamori-Adachi M, Yamada K, Taketani K, Kawauchi J, Tanaka-Okamoto
M, Miyoshi J, et al: Systems analysis of ATF3 in stress response
and cancer reveals opposing effects on pro-apoptotic genes in p53
pathway. PLoS One. 6:e268482011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hackl C, Lang SA, Moser C, Mori A,
Fichtner-Feigl S, Hellerbrand C, Dietmeier W, Schlitt HJ, Geissler
EK and Stoeltzing O: Activating transcription factor-3 (ATF3)
functions as a tumor suppressor in colon cancer and is up-regulated
upon heat-shock protein 90 (Hsp90) inhibition. BMC Cancer.
10:6682010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiaoyan L, Shengbing Z, Yu Z, Lin Z,
Chengjie L, Jingfeng L and Aimin H: Low expression of activating
transcription factor 3 in human hepatocellular carcinoma and its
clinicopathological significance. Int J Mol Med. 210:477–481.
2014.
|
|
11
|
Maciag AE, Nandurdikar RS, Hong SY,
Chakrapani H, Diwan B, Morris NL, Shami PJ, Shiao YH, Anderson LM,
Keefer LK and Saavedra JE: Activation of the c-Jun N-terminal
kinase/activating transcription factor 3 (ATF3) pathway
characterizes effective arylated diazeniumdiolate-based nitric
oxide-releasing anticancer prodrugs. J Med Chem. 54:7751–7758.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang J, Sun F, Sun W, Shi H, Yong Y, Liu S
and Liu L: Busuishengxue ranules mediate their effects upon
non-severe aplastic anemia via mitogen-activated protein
kinase/extracellular signal-regulated kinase pathway. J Tradit Chin
Med. 34:23–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Slattery ML, Lundgreen A and Wolff RK:
Dietary influence on MAPK-signaling pathways and risk of colon and
rectal cancer. Nutr Cancer. 65:729–738. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wei S, Wang H, Lu C, Malmut S, Zhang J,
Ren S, Yu G, Wang W, Tang DD and Yan C: The activating
transcription factor 3 protein suppresses the oncogenic function of
mutant p53 proteins. J Biol Chem. 289:8947–8959. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gargiulo G, Cesaroni M, Serresi M, de
Vries N, Hulsman D, Bruggeman SW, Lancini C and van Lohuizen M: In
vivo RNAi screen for BMI1 targets identifies TGF-β/BMP-ER stress
pathways as key regulators of neural- and malignant glioma-stem
cell homeostasis. Cancer Cell. 23:660–676. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang X, Li X and Guo B: KLF6 induces
apoptosis in prostate cancer cells through up-regulation of ATF3. J
Biol Chem. 283:29795–29801. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yuan X, Yu L, Li J, Xie G, Rong T, Zhang
L, Chen J, Meng Q, Irving AT, Wang D, et al: ATF3 suppresses
metastasis of bladder cancer by regulating gelsolin-mediated
remodeling of the actin cytoskeleton. Cancer Res. 73:3625–3637.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jan YH, Tsai HY, Yang CJ, Huang MS, Yang
YF, Lai TC, Lee CH, Jeng YM, Huang CY, Su JL, et al: Adenylate
kinase-4 is a marker of poor clinical outcomes that promotes
metastasis of lung cancer by downregulating the transcription
factor ATF3. Cancer Res. 72:5119–5129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Q, Mora-Jensen H, Weniger MA,
Perez-Galan P, Wolford C, Hai T, Ron D, Chen W, Trenkle W, Wiestner
A and Ye Y: ERAD inhibitors integrate ER stress with an epigenetic
mechanism to activate BH3-only protein NOXA in cancer cells. Proc
Natl Acad Sci USA. 106:2200–2205. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu D, Wolfgang CD and Hai T: Activating
transcription factor ATF3, a stress inducible gene, suppresses Ras
stimulated tumorigenesis. J Biol Chem. 281:10473–10481. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang G, Lunardi A, Zhang J, Chen Z, Ala U,
Webster KA, Tay Y, Gonzalez-Billalabeitia E, Egia A, Shaffer DR, et
al: Zbtb7a suppresses prostate cancer through repression of a
Sox9-dependent pathway for cellular senescence bypass and tumor
invasion. Nat Genet. 45:739–746. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feng J, Sun Q, Wu T, Lu J, Qu L, Sun Y,
Tian L, Zhang B, Li D and Liu M: Upregulation of ATF-3 is
correlated with prognosis and proliferation of laryngeal cancer by
regulating Cyclin D1 expression. Int J Clin Exp Pathol.
6:2064–2070. 2013.PubMed/NCBI
|
|
23
|
Fan F, Jin S, Amundson SA, Tong T, Fan W,
Zhao H, Zhu X, Mazzacurati L, Li X, Petrik KL, et al: ATF3
induction following DNA damages regulated by distinct signaling
pathways and over expression of ATF3 protein suppresses cells
growth. Oncogene. 21:7488–7496. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
James CG, Woods A, Underhill TM and Beier
F: The transcription factor ATF3 is up-regulated during chondrocyte
differentiation and represses cyclin D1 and A gene transcription.
BMC Mol Biol. 7:302006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zigler M, Villares GJ, Dobroff AS, Wang H,
Huang L, Braeuer RR, Kamiya T, Melnikova VO, Song R, Friedman R, et
al: Expression of Id-1 is regulated by MCAM/MUC18: A missing link
in melanoma progression. Cancer Res. 71:3494–3504. 2011. View Article : Google Scholar : PubMed/NCBI
|
